| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |